Map of thorough QT studies with QTc and J-Tpeakc biomarkers

Introduction: Recent studies have shown that J-TpeakC can differentiate predominant hERG potassium channel blockers with high Torsade risk from multi-channel blockers (hERG plus late sodium or calcium current block) with low Torsade risk. In this study, we have analyzed ECG effects caused by multipl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of electrocardiology 2017-11, Vol.50 (6), p.859-860
Hauptverfasser: Hosseini, Meisam, Johannesen, Lars, McAfee, Dustin C., Stockbridge, Norman, Strauss, David G., Vicente, Jose, Wong, Alexander
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 860
container_issue 6
container_start_page 859
container_title Journal of electrocardiology
container_volume 50
creator Hosseini, Meisam
Johannesen, Lars
McAfee, Dustin C.
Stockbridge, Norman
Strauss, David G.
Vicente, Jose
Wong, Alexander
description Introduction: Recent studies have shown that J-TpeakC can differentiate predominant hERG potassium channel blockers with high Torsade risk from multi-channel blockers (hERG plus late sodium or calcium current block) with low Torsade risk. In this study, we have analyzed ECG effects caused by multiple drugs from thorough QT (TQT) studies to explore QTc and J-TpeakC as indicators of predominant hERG versus multi-channel blockers.
doi_str_mv 10.1016/j.jelectrocard.2017.08.046
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2077575833</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022073617302911</els_id><sourcerecordid>2077575833</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1403-a162488752834e7d37f6b5f0b6c3acdf52118e7518e45f1827d4c19e1e80b0c73</originalsourceid><addsrcrecordid>eNqNkE9PAyEQxYnRxFr9DkTPuw6wLFRPpv5PjTGpZ8ICa9nWUmFX47eXph48epnJJO-9mfkhdEqgJEDq867s3MqZPgajoy0pEFGCLKGq99CIcEYLWTHYRyMASgsQrD5ERyl1ADChgo7Q5ZPe4NDifhFiGN4W-GWOUz9Y7xL-8v12NlivLX4s5hunlwY3PrzruHQxHaODVq-SO_ntY_R6ezOf3hez57uH6dWsMKQCVmhS00pKwalklROWibZueAtNbZg2tuWUEOkEz6XiLZFU2MqQiSNOQgNGsDE62-VuYvgYXOpVF4a4zisVBSG44JKxrLrYqUwMKUXXqk30-dJvRUBtYalO_YWltrAUSJVhZfP1zuzyH5_eRZWMd2vjrI_ZoWzw_4n5AUSid10</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2077575833</pqid></control><display><type>article</type><title>Map of thorough QT studies with QTc and J-Tpeakc biomarkers</title><source>ScienceDirect Journals (5 years ago - present)</source><creator>Hosseini, Meisam ; Johannesen, Lars ; McAfee, Dustin C. ; Stockbridge, Norman ; Strauss, David G. ; Vicente, Jose ; Wong, Alexander</creator><creatorcontrib>Hosseini, Meisam ; Johannesen, Lars ; McAfee, Dustin C. ; Stockbridge, Norman ; Strauss, David G. ; Vicente, Jose ; Wong, Alexander</creatorcontrib><description>Introduction: Recent studies have shown that J-TpeakC can differentiate predominant hERG potassium channel blockers with high Torsade risk from multi-channel blockers (hERG plus late sodium or calcium current block) with low Torsade risk. In this study, we have analyzed ECG effects caused by multiple drugs from thorough QT (TQT) studies to explore QTc and J-TpeakC as indicators of predominant hERG versus multi-channel blockers.</description><identifier>ISSN: 0022-0736</identifier><identifier>EISSN: 1532-8430</identifier><identifier>DOI: 10.1016/j.jelectrocard.2017.08.046</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Biomarkers ; Electrocardiography ; Potassium ; Side effects</subject><ispartof>Journal of electrocardiology, 2017-11, Vol.50 (6), p.859-860</ispartof><rights>2017</rights><rights>Copyright Elsevier Science Ltd. Nov/Dec 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jelectrocard.2017.08.046$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids></links><search><creatorcontrib>Hosseini, Meisam</creatorcontrib><creatorcontrib>Johannesen, Lars</creatorcontrib><creatorcontrib>McAfee, Dustin C.</creatorcontrib><creatorcontrib>Stockbridge, Norman</creatorcontrib><creatorcontrib>Strauss, David G.</creatorcontrib><creatorcontrib>Vicente, Jose</creatorcontrib><creatorcontrib>Wong, Alexander</creatorcontrib><title>Map of thorough QT studies with QTc and J-Tpeakc biomarkers</title><title>Journal of electrocardiology</title><description>Introduction: Recent studies have shown that J-TpeakC can differentiate predominant hERG potassium channel blockers with high Torsade risk from multi-channel blockers (hERG plus late sodium or calcium current block) with low Torsade risk. In this study, we have analyzed ECG effects caused by multiple drugs from thorough QT (TQT) studies to explore QTc and J-TpeakC as indicators of predominant hERG versus multi-channel blockers.</description><subject>Biomarkers</subject><subject>Electrocardiography</subject><subject>Potassium</subject><subject>Side effects</subject><issn>0022-0736</issn><issn>1532-8430</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqNkE9PAyEQxYnRxFr9DkTPuw6wLFRPpv5PjTGpZ8ICa9nWUmFX47eXph48epnJJO-9mfkhdEqgJEDq867s3MqZPgajoy0pEFGCLKGq99CIcEYLWTHYRyMASgsQrD5ERyl1ADChgo7Q5ZPe4NDifhFiGN4W-GWOUz9Y7xL-8v12NlivLX4s5hunlwY3PrzruHQxHaODVq-SO_ntY_R6ezOf3hez57uH6dWsMKQCVmhS00pKwalklROWibZueAtNbZg2tuWUEOkEz6XiLZFU2MqQiSNOQgNGsDE62-VuYvgYXOpVF4a4zisVBSG44JKxrLrYqUwMKUXXqk30-dJvRUBtYalO_YWltrAUSJVhZfP1zuzyH5_eRZWMd2vjrI_ZoWzw_4n5AUSid10</recordid><startdate>201711</startdate><enddate>201711</enddate><creator>Hosseini, Meisam</creator><creator>Johannesen, Lars</creator><creator>McAfee, Dustin C.</creator><creator>Stockbridge, Norman</creator><creator>Strauss, David G.</creator><creator>Vicente, Jose</creator><creator>Wong, Alexander</creator><general>Elsevier Inc</general><general>Elsevier Science Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope></search><sort><creationdate>201711</creationdate><title>Map of thorough QT studies with QTc and J-Tpeakc biomarkers</title><author>Hosseini, Meisam ; Johannesen, Lars ; McAfee, Dustin C. ; Stockbridge, Norman ; Strauss, David G. ; Vicente, Jose ; Wong, Alexander</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1403-a162488752834e7d37f6b5f0b6c3acdf52118e7518e45f1827d4c19e1e80b0c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Biomarkers</topic><topic>Electrocardiography</topic><topic>Potassium</topic><topic>Side effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hosseini, Meisam</creatorcontrib><creatorcontrib>Johannesen, Lars</creatorcontrib><creatorcontrib>McAfee, Dustin C.</creatorcontrib><creatorcontrib>Stockbridge, Norman</creatorcontrib><creatorcontrib>Strauss, David G.</creatorcontrib><creatorcontrib>Vicente, Jose</creatorcontrib><creatorcontrib>Wong, Alexander</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><jtitle>Journal of electrocardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hosseini, Meisam</au><au>Johannesen, Lars</au><au>McAfee, Dustin C.</au><au>Stockbridge, Norman</au><au>Strauss, David G.</au><au>Vicente, Jose</au><au>Wong, Alexander</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Map of thorough QT studies with QTc and J-Tpeakc biomarkers</atitle><jtitle>Journal of electrocardiology</jtitle><date>2017-11</date><risdate>2017</risdate><volume>50</volume><issue>6</issue><spage>859</spage><epage>860</epage><pages>859-860</pages><issn>0022-0736</issn><eissn>1532-8430</eissn><abstract>Introduction: Recent studies have shown that J-TpeakC can differentiate predominant hERG potassium channel blockers with high Torsade risk from multi-channel blockers (hERG plus late sodium or calcium current block) with low Torsade risk. In this study, we have analyzed ECG effects caused by multiple drugs from thorough QT (TQT) studies to explore QTc and J-TpeakC as indicators of predominant hERG versus multi-channel blockers.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/j.jelectrocard.2017.08.046</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-0736
ispartof Journal of electrocardiology, 2017-11, Vol.50 (6), p.859-860
issn 0022-0736
1532-8430
language eng
recordid cdi_proquest_journals_2077575833
source ScienceDirect Journals (5 years ago - present)
subjects Biomarkers
Electrocardiography
Potassium
Side effects
title Map of thorough QT studies with QTc and J-Tpeakc biomarkers
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T12%3A57%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Map%20of%20thorough%20QT%20studies%20with%20QTc%20and%20J-Tpeakc%20biomarkers&rft.jtitle=Journal%20of%20electrocardiology&rft.au=Hosseini,%20Meisam&rft.date=2017-11&rft.volume=50&rft.issue=6&rft.spage=859&rft.epage=860&rft.pages=859-860&rft.issn=0022-0736&rft.eissn=1532-8430&rft_id=info:doi/10.1016/j.jelectrocard.2017.08.046&rft_dat=%3Cproquest_cross%3E2077575833%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2077575833&rft_id=info:pmid/&rft_els_id=S0022073617302911&rfr_iscdi=true